HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC

NCT02856126 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

214

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

PROCEDURE: Hepatic arterial infusion chemotherapy
PROCEDURE: Transarterial chemoembolization
DRUG: TACE regimen
DRUG: HAIC Regimen
DRUG: Oral Sorafenib

Sponsor

Sun Yat-sen University